ECIGS really must have arrived because I now see them front and center in the bodegas of NYC.
Blu and nJoy are everywhere in Manhattan now.
No question that ecigs are here to stay until some new health scare or serious regulations are put in place. The science appears to have already shown ecigs far safer than traditional cigs, so the real issue is taxation and regulation.
With public health professionals such as myself split on the issue, it's hard to see any widespread bans or serious taxation put in place given the strong likelihood that ecigs do not substantially raise one's risk of heart disease or lung cancer beyond what a nicotine patch or gum program would.
Even with regulatory action, it's hard to see how pharmacies and bodegas wouldn't prefer selling e cigs, and heavy taxation would likely require a consensus against the product that simply cannot be obtained at this time in the public health community. I'm buying more VPCO..
Sentiment: Strong Buy
I suppose that logic is what retail investors are using.
TWTR is priced at 50x sales and 35x book.
This is way beyond LNKD.
I don't think one can overstate the bubble that TWTR is enjoying.
Fascinating to see.
Will TWTR get to $60 or $70 before FB? Apparently so.
Will the TWTR bubble at some point soon. Probably.
I AM a public health physician, and even if there is HALF of the carcinogens in vapor smoke it STILL would be a great advance in harm reduction for society.
People are ALWAYS going to want alcohol, caffeine and NICOTINE. It's foolhardy to suggest that eCigs will promote something that is already ingrained in western society. For 500 years people want nicotine, and they will find a way to get it.
There is no evidence of ecigs causing nicotine od, or cancer, or proof that it would lead to smoking that wouldn't otherwise take place. No one is linking ecigs with second hand smoke dangers, and finally the stench is taken care of.
With eCigs, NON smokers, asthmatics, and people who are sick and tired of the stench of conventional cigs will feel much safer and breathe easier. More study is necessary, but ANYTHING that isn't immediately harmful that gets regular cigs out of the hands of American smokers is a public health and investor gift.
I've worked for the NYC Health Dept. Ecig smoking is probably less hazardous than breathing in NYC or LA pollution until someone proves otherwise. VPCO might get bought out but only thru smaller players can the industry be challenged to produce better and safer products for users and non smokers.
I'm an MD, MPH, and I'm proud that VPCO is NOT part of BIG tobacco, so I'm buying as much VPCO stock as I can afford.
Sentiment: Strong Buy
Very strange company indeed.
Why aren't they shopping the procedure around to MS societies?
There seems so much promise.
Is Victor already so rich from derm and lipo that he isn't interested anymore?
Why hire Hirshman who is an ethics expert if the thing is going under?
Seems like a good buy below $4. Anyone with downside cautions?
Very steady customer stream, great divvy, great tecnicals, about to uplisted, superb buyout target.
Hard to see the downside.
I'm thinking of buying more into $4.
Hanging on to this because he is a serious turnaround CEO.
I think there is still value here, but obviously he has to execute perfectly
and somehow spin that call in two wks.
I'm betting he can do it. long odds but I am rooting for BBRY !
Your thesis may be correct. However, you leave out the very real potential for a buyout payday.
Since there are only a handful of companies attracting attention or market share, VPCO remains a potential takeover target at double its current price. Pure and simple - when you are talking about big tobacco, they can buy out ALL the companies (except nJoy). Any tobacco firm could easily buyout VPCO, GLLA and eCig in a week for double or triple the price, just to trim the market.
Therefore it's worth speculating w/ VPCO under $2.
Sentiment: Strong Buy
You might be right. However, there are at least 2 seeking alpha articles saying a turnaround is possible and that the overselling was premature.
The SEC investigation is not coming out of the blue apparently, and the despite a deluge of bad news, the stock didn't drop to $6, which it could have.
CEOs only buy stock in their own company at $8.87 a share for one reason - they believe the stock will go over $9. JCP has plenty of liquidity and can afford to burn thru some cash into 2014. It's a good speculative turnaround play. No risk, no reward. We'll see Monday.